News Home

Eton Pharmaceuticals Inc (ETON) Stock: Do Analysts Think You Should Hold?

Thursday, October 28, 2021 10:38 AM | InvestorsObserver Analysts
Eton Pharmaceuticals Inc (ETON) Stock: Do Analysts Think You Should Hold?

InvestorsObserver is giving Eton Pharmaceuticals Inc (ETON) an Analyst Rating Rank of 75, meaning ETON is ranked higher by analysts than 75% of stocks. The average price target for ETON is $12 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating ETON a Strong Buy today. Find out what this means to you and get the rest of the rankings on ETON!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Eton Pharmaceuticals Inc Stock Today?

Eton Pharmaceuticals Inc (ETON) stock is lower by -3.56% while the S&P 500 has gained 0.64% as of 10:22 AM on Thursday, Oct 28. ETON is lower by -$0.20 from the previous closing price of $5.63 on volume of 1,023,926 shares. Over the past year the S&P 500 is higher by 40.04% while ETON is lower by -28.27%. ETON lost -$0.56 per share the over the last 12 months. Click Here to get the full Stock Report for Eton Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App